Bifidobacterium pseudolongum
Selected indexed studies
- Bifidobacterium pseudolongum-generated acetate suppresses non-alcoholic fatty liver disease-associated hepatocellular carcinoma. (J Hepatol, 2023) [PMID:37459922]
- Indole-3-acetic acid alleviates DSS-induced colitis by promoting the production of R-equol from Bifidobacterium pseudolongum. (Gut Microbes, 2024) [PMID:38528729]
- Fasting-mimicking diet-enriched Bifidobacterium pseudolongum suppresses colorectal cancer by inducing memory CD8(+) T cells. (Gut, 2025) [PMID:39870395]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Fasting-mimicking diet-enriched Bifidobacterium pseudolongum suppresses colorectal cancer by inducing memory CD8(+) T cells. (2025) pubmed
- Bifidobacterium pseudolongum-generated acetate suppresses non-alcoholic fatty liver disease-associated hepatocellular carcinoma. (2023) pubmed
- Indole-3-acetic acid alleviates DSS-induced colitis by promoting the production of R-equol from Bifidobacterium pseudolongum. (2024) pubmed
- Bifidobacterium pseudolongum-Derived Bile Acid from Dietary Carvacrol and Thymol Supplementation Attenuates Colitis via cGMP-PKG-mTORC1 Pathway. (2024) pubmed
- Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy. (2020) pubmed
- Time-restricted feeding mitigates Alzheimer's disease-associated cognitive impairments via a B. pseudolongum-propionic acid-FFAR3 axis. (2025) pubmed
- Bifidobacterium pseudolongum attenuates morphine tolerance via TLR4 in a male mouse model of bone cancer pain. (2025) pubmed
- Bifidobacterium pseudolongum reduces triglycerides by modulating gut microbiota in mice fed high-fat food. (2020) pubmed
- Microbiota-derived acetate enhances host antiviral response via NLRP3. (2023) pubmed
- Multiomics reveals the ameliorating effect and underlying mechanism of aqueous extracts of polygonatum sibiricum rhizome on obesity and liver fat accumulation in high-fat diet-fed mice. (2024) pubmed